Genuine Parts Company (GPC) Touches $95.48 Formed H&S; Redmile Group Has Lifted By $6.78 Million Its Vertex Pharmaceuticals (VRTX) Position

Genuine Parts Company (GPC) formed inverse H&S with $103.12 target or 8.00% above today’s $95.48 share price. Genuine Parts Company (GPC) has $14.00B valuation. The stock decreased 0.20% or $0.19 during the last trading session, reaching $95.48. About 516,863 shares traded. Genuine Parts Company (NYSE:GPC) has declined 1.45% since December 29, 2016 and is downtrending. It has underperformed by 18.15% the S&P500.

Redmile Group Llc increased Vertex Pharmaceuticals Inc (VRTX) stake by 30.88% reported in 2017Q3 SEC filing. Redmile Group Llc acquired 44,600 shares as Vertex Pharmaceuticals Inc (VRTX)’s stock rose 33.61%. The Redmile Group Llc holds 189,008 shares with $28.74M value, up from 144,408 last quarter. Vertex Pharmaceuticals Inc now has $38.23B valuation. The stock decreased 0.25% or $0.38 during the last trading session, reaching $151.17. About 957,374 shares traded. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has risen 45.69% since December 29, 2016 and is uptrending. It has outperformed by 28.99% the S&P500.

Among 27 analysts covering Vertex Pharmaceuticals (NASDAQ:VRTX), 23 have Buy rating, 0 Sell and 4 Hold. Therefore 85% are positive. Vertex Pharmaceuticals had 79 analyst reports since July 31, 2015 according to SRatingsIntel. On Tuesday, July 18 the stock rating was maintained by BMO Capital Markets with “Buy”. BMO Capital Markets maintained it with “Buy” rating and $182.0 target in Monday, September 25 report. Morgan Stanley upgraded it to “Overweight” rating and $148 target in Friday, October 2 report. The firm has “Market Perform” rating by William Blair given on Tuesday, November 1. Argus Research upgraded Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) rating on Monday, September 28. Argus Research has “Buy” rating and $126 target. The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has “Equal-Weight” rating given on Tuesday, November 29 by Barclays Capital. The stock has “Buy” rating by Janney Capital on Wednesday, July 19. The firm earned “Buy” rating on Wednesday, October 5 by Jefferies. Needham maintained it with “Buy” rating and $195.0 target in Thursday, October 26 report. Oppenheimer upgraded Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) rating on Sunday, July 9. Oppenheimer has “Buy” rating and $15000 target.

Since July 31, 2017, it had 0 insider buys, and 20 insider sales for $62.07 million activity. 75,000 shares were sold by SMITH IAN F, worth $10.88M. $830,960 worth of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares were sold by Chodakewitz Jeffrey. Another trade for 4,250 shares valued at $661,810 was made by Arbuckle Stuart A on Thursday, August 3. Sachdev Amit had sold 40,000 shares worth $5.80 million. LEIDEN JEFFREY M sold $1.69M worth of stock. Silva Paul M also sold $195,670 worth of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares. On Thursday, August 31 the insider ALTSHULER DAVID sold $287,360.

Redmile Group Llc decreased Regenxbio Inc stake by 50,999 shares to 1.67M valued at $54.95M in 2017Q3. It also reduced Audentes Therapeutics Inc stake by 170,284 shares and now owns 1.29 million shares. Cascadian Therapeutics Inc was reduced too.

Investors sentiment increased to 1.62 in 2017 Q3. Its up 0.11, from 1.51 in 2017Q2. It improved, as 32 investors sold VRTX shares while 151 reduced holdings. 79 funds opened positions while 217 raised stakes. 231.42 million shares or 0.04% more from 231.33 million shares in 2017Q2 were reported. Icon Advisers Com holds 54,463 shares or 0.58% of its portfolio. Bowen Hanes Inc holds 1.18% or 165,000 shares in its portfolio. Glenmede Trust Na reported 1,754 shares. Mitsubishi Ufj Tru And Bk Corp holds 0.19% or 660,390 shares. Paloma Prtn invested 0.02% in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Sei Invests holds 0.07% or 122,519 shares. Tower Research Ltd Limited Liability Company (Trc) has 2,389 shares. Royal Bank Of Canada, Ontario – Canada-based fund reported 163,498 shares. Los Angeles Capital Management & Equity Research Incorporated invested in 0.07% or 85,339 shares. Susquehanna Int Group Inc Llp holds 9,604 shares. Dekabank Deutsche Girozentrale invested in 0.18% or 153,362 shares. Moreover, Voya Investment Management Lc has 0.03% invested in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Tekla Mngmt Ltd Liability Com reported 731,123 shares. Invesco holds 3.10 million shares. Regions Finance Corp holds 11,347 shares.

Among 12 analysts covering Genuine Parts Company (NYSE:GPC), 2 have Buy rating, 3 Sell and 7 Hold. Therefore 17% are positive. Genuine Parts Company has $102 highest and $85.0 lowest target. $95.50’s average target is 0.02% above currents $95.48 stock price. Genuine Parts Company had 28 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Genuine Parts Company (NYSE:GPC) earned “Neutral” rating by Wedbush on Thursday, October 20. The rating was initiated by Atlantic Securities on Wednesday, December 14 with “Neutral”. RBC Capital Markets maintained Genuine Parts Company (NYSE:GPC) on Friday, September 8 with “Hold” rating. The stock has “Hold” rating by Jefferies on Wednesday, October 11. RBC Capital Markets maintained Genuine Parts Company (NYSE:GPC) rating on Thursday, April 20. RBC Capital Markets has “Sector Perform” rating and $96 target. The firm has “Buy” rating by Gabelli given on Friday, July 21. Jefferies maintained Genuine Parts Company (NYSE:GPC) rating on Wednesday, April 19. Jefferies has “Hold” rating and $95 target. The firm earned “Buy” rating on Tuesday, September 15 by Jefferies. The rating was upgraded by Goldman Sachs to “Neutral” on Thursday, January 19. Gabelli upgraded the shares of GPC in report on Tuesday, October 20 to “Buy” rating.

Investors sentiment increased to 0.96 in Q3 2017. Its up 0.06, from 0.9 in 2017Q2. It is positive, as 46 investors sold Genuine Parts Company shares while 195 reduced holdings. 55 funds opened positions while 176 raised stakes. 108.15 million shares or 1.25% more from 106.82 million shares in 2017Q2 were reported. Paloma Prtnrs Mngmt Communication accumulated 0.01% or 5,668 shares. Moreover, Cornerstone Advsrs has 0.01% invested in Genuine Parts Company (NYSE:GPC) for 138 shares. First Midwest Bancshares Tru Division has 8,629 shares. Mechanics Bank & Trust Department has invested 0.26% of its portfolio in Genuine Parts Company (NYSE:GPC). Beach Counsel Pa accumulated 11,627 shares. Willis Investment Counsel holds 1.61% or 232,800 shares in its portfolio. Guggenheim Capital Limited Liability holds 0.1% in Genuine Parts Company (NYSE:GPC) or 429,214 shares. First Trust Advsr Limited Partnership reported 0.09% in Genuine Parts Company (NYSE:GPC). Keybank Natl Association Oh owns 115,974 shares. Veritable Lp invested in 0.01% or 5,570 shares. Schwab Charles Inv Mgmt has 755,065 shares. Brown Advisory Incorporated holds 11,650 shares or 0% of its portfolio. Australia-based Westpac Banking has invested 0.02% in Genuine Parts Company (NYSE:GPC). Cubic Asset Management Llc reported 58,941 shares or 1.59% of all its holdings. Prudential Fin Inc has invested 0.05% in Genuine Parts Company (NYSE:GPC).

Analysts await Genuine Parts Company (NYSE:GPC) to report earnings on February, 20. They expect $1.06 EPS, up 3.92% or $0.04 from last year’s $1.02 per share. GPC’s profit will be $155.41 million for 22.52 P/E if the $1.06 EPS becomes a reality. After $1.16 actual EPS reported by Genuine Parts Company for the previous quarter, Wall Street now forecasts -8.62% negative EPS growth.